Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies

被引：0
|
作者：
El Darsa, Haidar [1 ,2 ]
Massoud, Radwan [1 ,2 ]
Zahreddine, Ammar [1 ,2 ]
Bazarbachi, Ali [1 ,2 ]
El-Cheikh, Jean [1 ,2 ]
机构：
[1] Amer Univ Beirut, Dept Internal Med, Bone Marrow Transplantat Program, Beirut, Lebanon
[2] Amer Univ Beirut, Dept Internal Med, Div Hematol & Oncol, Beirut, Lebanon
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷
关键词：
D O I：
10.1016/j.clml.2017.07.243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RES-133
引用
收藏
页码：S390 / S391
页数：2
相关论文
共 50 条
  • [31] Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis
    Shouval, Roni
    Vega, Yakov
    Fein, Joshua A.
    Danylesko, Ivetta
    Tov, Noga Shem
    Yerushalmi, Ronit
    Sobas, Marta
    Czyz, Anna
    Nagler, Arnon
    Shimoni, Avichai
    BONE MARROW TRANSPLANTATION, 2020, 55 (01) : 147 - 156
  • [32] Total body irradiation, busulfan and cyclophosphamide as a conditioning regimen for allogeneic bone marrow transplantation for patients with hematological malignancies
    Kai, S
    Misawa, M
    Hara, H
    JAPANESE JOURNAL OF TRANSPLANTATION, 1999, 34 (04) : 191 - 199
  • [33] Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosis
    Roni Shouval
    Yakov Vega
    Joshua A. Fein
    Ivetta Danylesko
    Noga Shem Tov
    Ronit Yerushalmi
    Marta Sobas
    Anna Czyż
    Arnon Nagler
    Avichai Shimoni
    Bone Marrow Transplantation, 2020, 55 : 147 - 156
  • [34] The Impact of Age in Allogeneic Stem Cell Transplantation with Thiotepa Busulfan and Fludarabine (TBF) for Myelofibrosis : A Retrospective Analysis
    SORA, Federica
    Chiusolo, Patrizia
    Giammarco, Sabrina
    Innocenti, Idanna
    Autore, Francesco
    Metafuni, Elisabetta
    Galli, Eugenio
    Limongello, Maria Assunta
    Laurenti, Luca
    Sica, Simona
    Bacigalupo, Andrea
    BLOOD, 2021, 138
  • [35] Thiotepa-busulfan-fludarabine conditioning as a promising approach prior to haploidentical allogeneic hematopoietic stem cell transplantation in hematological malignancies with extramedullary involvement: Insights from a single center
    Huang, Xianbo
    Wu, Xianhui
    Wang, Shasha
    Ren, Yanling
    Xu, Yu
    Mei, Chen
    Jin, Jie
    Tong, Hongyan
    Qian, Jiejing
    LEUKEMIA RESEARCH, 2024, 147
  • [36] Fludarabine and busulfan as conditioning regimen in allogeneic stem cell transplantation: comparison with BuCy2
    Fedele, R.
    Moscato, T.
    Massara, E.
    Messina, G.
    Iacopino, O.
    Pontari, A.
    Spiniello, E.
    Callea, I.
    Garreffa, C.
    Martino, M.
    Console, G.
    Gallo, G.
    Princi, D.
    Monteleone, R.
    Irrera, G.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S418 - S419
  • [37] Allogeneic Hematopoietic Stem Cell Transplantation after Conditioning Regimens with Fludarabine/melphalan or Fludarabine/busulfan for Patients with Hematological Malignancies: A Single-center Analysis
    Yamamoto, Wataru
    Andou, Taiki
    Itabashi, Megumi
    Koyama, Satoshi
    Ishii, Yoshimi
    Numata, Ayumi
    Motohashi, Kenji
    Hagihara, Maki
    Matsumoto, Kenji
    Fujisawa, Shin
    INTERNAL MEDICINE, 2016, 55 (13) : 1721 - 1727
  • [38] CLOFARABINE6FLUDARABINE WITH IV BUSULFAN AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED, REFRACTORY MYELOID LEUKEMIA (ML) AND MDS
    Andersson, B. S.
    de, Lima M.
    Valdez, B. C.
    Thall, P. F.
    Worth, L. L.
    Popat, U.
    Jones, R. B.
    Shpall, E. J.
    Madden, T.
    McAdams, P. L.
    Alousi, A. M.
    Rondon, G.
    Kebriaei, P.
    Champlin, R. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S271 - S272
  • [39] Fludarabine/cyclophosphamide non-myeloablative allogeneic stem cell transplantation for lymphoid malignancies
    Auer, R. L.
    MacDougall, F.
    Oakervee, H. E.
    Cavenagh, J. C.
    Gribben, J. G.
    Lister, T. A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 70 - 70
  • [40] Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma
    Grisariu, Sigal
    Shapira, Michael Y.
    Or, Reuven
    Avni, Batia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (04): : 272 - 279
12345